miR-637 is able to modulating the Jak/STAT3, Wnt/β-catenin, and PI3K/Akt signaling pathways; it is downregulated in cancer and is associated to larger tumors and later tumor node metastasis staging in cancer patients (89). Here, AKT1 is linked to neoplasm.